Vera Therapeutics (NASDAQ:VERA) Price Target Raised to $61.00
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective increased by Guggenheim from $59.00 to $61.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on the stock. Several other research analysts have also issued reports on the company. The Goldman Sachs Group began coverage on Vera Therapeutics in a […]
Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective increased by Guggenheim from $59.00 to $61.00 in a report issued on Thursday,Benzinga reports. They currently have a buy rating on the stock. Several other research analysts have also issued reports on the company. The Goldman Sachs Group began coverage on Vera Therapeutics in a […]
